Core Insights - Core Laboratories Inc. (CLB) is expected to report fourth-quarter 2025 results on February 4, with a consensus estimate of earnings at 20 cents per share and revenues at $132 million [1][7]. Q3 Earnings Highlights - In the last reported quarter, CLB's adjusted earnings were 22 cents per share, exceeding the consensus estimate by 3 cents, while operating revenues reached $134.5 million, surpassing the estimate of $128 million due to increased demand for laboratory analytical and completion diagnostic services internationally [2]. Earnings Surprise History - CLB has missed the Zacks Consensus Estimate in two of the last four quarters and beat it in the other two, resulting in an average surprise of 2.58% [3]. - The consensus estimate for fourth-quarter 2025 earnings has remained unchanged over the past 30 days, indicating a year-over-year decline of 9.09%, while revenue estimates show a 2.35% increase compared to the previous year [3]. Factors Influencing Q4 Performance - CLB's revenue is anticipated to improve due to strong performance in both the Reservoir Description and Production Enhancement segments [4]. - However, rising costs are expected to impact the bottom line, with total operating expenses projected at $117.7 million, a 2.3% increase from the previous quarter, and costs of services and product sales expected to reach $108.4 million, up 2% from last quarter [5]. Earnings Prediction Model - The Zacks model does not predict an earnings beat for CLB this quarter, as the Earnings ESP is 0.00% and the company holds a Zacks Rank of 3 (Hold) [6][8].